DEXTENZA

Ocular Therapeutix, Inc.🇺🇸 United States

FDA Page

Effective Date: Oct 19, 2021
Approval ID: 7514e6b8-c33f-4fbf-8810-ef520e1eb4bd
Products: 1 registered
Version: 14

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DEXTENZA safely and effectively. See full prescribing information for DEXTENZA. DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular useInitial U.S. Approval: 1958

Quick Stats

Total Products1

Labelers2

Label Sections33

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.